As healthcare facilities and physician practices across the country are gradually expanding in-person care services, patient and staff safety is crucial in determining an ideal continuity of care approach. For patients with gastrointestinal (GI) symptoms, it is especially important to select a diagnostic and treatment plan that reduces stress and anxiety, which have been linked to causing additional GI complications including flare ups, digestion and motility issues, and buildup of bacteria in the gut.
Here are three best practices that promote the wellbeing of healthcare providers and their patients suffering from GI ailments during the COVID-19 pandemic and beyond.
Commonwealth Diagnostics International, Inc. (CDI) provides non-invasive at-home breath test kits for Small Intestinal Bacterial Overgrowth (SIBO) and carbohydrate malabsorption disorders that help physicians obtain accurate results to inform diagnostic and treatment plans. CDI’s diagnostic test kits not only help support meaningful health outcomes, but they also are easy-to-use, quick, safe and cost-effective.
While there are various ways to address patient and staff safety during this challenging time, at-home diagnostic test kits ensure continuity of care, provide an extra level of comfort for patients, and help healthcare providers better manage resource restrictions.
Get started with CDI’s at-home breath test kits today.